Sequoia Financial Advisors LLC Invests $235,000 in Bath & Body Works, Inc. (NYSE:BBWI)

Sequoia Financial Advisors LLC purchased a new position in Bath & Body Works, Inc. (NYSE:BBWI) in the 4th quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund purchased 5,452 shares of the company’s stock, valued at approximately $235,000.

Several other large investors also recently modified their holdings of BBWI. Davidson Kempner Capital Management LP grew its holdings in shares of Bath & Body Works by 2,360.0% in the first quarter. Davidson Kempner Capital Management LP now owns 2,391,104 shares of the company’s stock worth $87,467,000 after acquiring an additional 2,293,904 shares during the period. Darsana Capital Partners LP bought a new stake in shares of Bath & Body Works in the third quarter worth $76,050,000. Norges Bank bought a new stake in shares of Bath & Body Works in the fourth quarter worth $87,870,000. Renaissance Technologies LLC bought a new stake in shares of Bath & Body Works in the first quarter worth $84,383,000. Finally, Alliancebernstein L.P. grew its holdings in Bath & Body Works by 507.2% during the fourth quarter. Alliancebernstein L.P. now owns 1,964,651 shares of the company’s stock valued at $82,790,000 after purchasing an additional 1,641,108 shares during the period. Institutional investors own 95.14% of the company’s stock.

Insider Buying and Selling

In other Bath & Body Works news, insider Thomas E. Mazurek sold 4,285 shares of the company’s stock in a transaction that occurred on Wednesday, March 27th. The stock was sold at an average price of $48.89, for a total transaction of $209,493.65. Following the sale, the insider now directly owns 45,992 shares in the company, valued at $2,248,548.88. The sale was disclosed in a document filed with the SEC, which is available at the SEC website. 0.19% of the stock is owned by company insiders.

Bath & Body Works Trading Up 0.3 %

NYSE:BBWI opened at $43.99 on Friday. The company has a market capitalization of $9.89 billion, a P/E ratio of 11.43, a P/E/G ratio of 1.40 and a beta of 1.86. Bath & Body Works, Inc. has a 12 month low of $27.30 and a 12 month high of $50.34. The business’s 50-day moving average is $46.15 and its 200 day moving average is $40.08.

Bath & Body Works (NYSE:BBWI) last posted its earnings results on Thursday, February 29th. The company reported $2.06 EPS for the quarter, topping analysts’ consensus estimates of $1.85 by $0.21. The company had revenue of $2.91 billion for the quarter, compared to the consensus estimate of $2.84 billion. Bath & Body Works had a negative return on equity of 37.01% and a net margin of 11.82%. The firm’s revenue for the quarter was up .8% on a year-over-year basis. During the same period in the previous year, the business earned $1.86 earnings per share. On average, research analysts forecast that Bath & Body Works, Inc. will post 3.3 earnings per share for the current year.

Bath & Body Works Dividend Announcement

The company also recently announced a quarterly dividend, which was paid on Friday, March 8th. Investors of record on Friday, February 23rd were given a $0.20 dividend. The ex-dividend date was Thursday, February 22nd. This represents a $0.80 dividend on an annualized basis and a dividend yield of 1.82%. Bath & Body Works’s dividend payout ratio is currently 20.78%.

Analysts Set New Price Targets

Several analysts have issued reports on the company. TD Cowen boosted their price target on Bath & Body Works from $35.00 to $55.00 and gave the company an “outperform” rating in a report on Friday, March 1st. Piper Sandler boosted their price target on Bath & Body Works from $44.00 to $45.00 and gave the company a “neutral” rating in a report on Tuesday, April 9th. BMO Capital Markets boosted their price target on Bath & Body Works from $48.00 to $50.00 and gave the company an “outperform” rating in a report on Friday, March 1st. Wells Fargo & Company boosted their price target on Bath & Body Works from $40.00 to $42.00 and gave the company an “equal weight” rating in a report on Friday, March 1st. Finally, Evercore ISI boosted their price target on Bath & Body Works from $30.00 to $45.00 and gave the company an “in-line” rating in a report on Friday, March 1st. One equities research analyst has rated the stock with a sell rating, seven have given a hold rating and six have issued a buy rating to the company. According to MarketBeat, the company has a consensus rating of “Hold” and a consensus price target of $46.33.

About Bath & Body Works

Bath & Body Works, Inc operates a specialty retailer of home fragrance, body care, and soaps and sanitizer products. It sells its products under the Bath & Body Works, White Barn, and other brand names through retail stores and e-commerce sites located in the United States and Canada, as well as through international stores operated by partners under franchise, license, and wholesale arrangements.